What have pharmacies paid for Entecavir since 2013?
What pharmacies pay, not what you pay. Entecavir has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged. Entecavir 0.5 MG Tablet: $30.12 per unit at the 2014 survey and $0.246 at 2026 (−99%).
Not medical or financial advice. This page reports what pharmacies pay to acquire a drug, from the CMS NADAC survey. It is not what you will be charged, and it says nothing about which medicine is right for you. Ask your pharmacist or prescriber.
Entecavir2 products in NADAC
2products with a price history
Entecavir has 2 products in the CMS NADAC survey, 2 products with year-end prices in more than one year. NADAC is what pharmacies pay to acquire a drug, not what a patient is charged.
Between each product's first and latest year-end survey, 1 product costs pharmacies less and none costs more, by more than 5 percent, per unit as CMS states it.
1 of the changes rest on fewer than 3 priced NDCs at one end and are marked thin: a median over one or two NDCs reflects which NDCs were priced as much as a price movement.
This is a per-unit acquisition cost, not a retail price, a copay or an insurer's price, and it says nothing about why a price moved.
Entecavir 0.5 MG Tablet
Generic
$30.12 per unit at the 2014 year-end survey (3 NDCs) and $0.246 at the 2026 survey (13 NDCs): −99%.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$30.12
3
2015 (2015-12-30)
$22.40
6
2016 (2016-12-28)
$13.73
10
2017 (2017-12-27)
$4.38
11
2018 (2018-12-26)
$1.93
16
2019 (2019-12-25)
$1.38
14
2020 (2020-12-30)
$1.14
15
2021 (2021-12-29)
$0.844
16
2022 (2022-12-28)
$0.680
14
2023 (2023-12-27)
$0.556
14
2024 (2024-12-25)
$0.290
13
2025 (2025-12-31)
$0.221
12
2026 (2026-11-11)
$0.246
13
Entecavir 1 MG Tablet
Generic
$30.35 per unit at the 2014 year-end survey (2 NDCs) and $0.358 at the 2026 survey (9 NDCs): −99%, a thin comparison.
year-end median across the NDCs pricedlowest to highest NDC
Year-end survey
Median per unit
Lowest to highest
NDCs priced
2014 (2014-12-31)
$30.35
2
2015 (2015-12-30)
$23.56
4
2016 (2016-12-28)
$12.62
5
2017 (2017-12-27)
$4.28
6
2018 (2018-12-26)
$2.21
11
2019 (2019-12-25)
$1.62
10
2020 (2020-12-30)
$1.30
10
2021 (2021-12-29)
$0.707
10
2022 (2022-12-28)
$0.743
10
2023 (2023-12-27)
$0.668
9
2024 (2024-12-25)
$0.438
9
2025 (2025-12-31)
$0.415
8
2026 (2026-11-11)
$0.358
9
CMS National Average Drug Acquisition Cost, year-end surveys 2013 to 2026. A pharmacy acquisition cost, not a retail price. About NADAC.
Where does Entecavir sit on the generic price cliff?
Entecavir 0.5 MG Tablet: the first generic approval in its Orange Book group is dated 2014. Its year-end acquisition cost in 2026 is 1% of its first observed year-end price (2014). The median matched product, 12 years after its first generic approval, is at 16% (the middle half runs from 6% to 34%), so this product is below that middle half.
median of 200 matched productsmiddle halfeach productEntecavir 0.5 MG Tablet
This is a pattern in matched products. It does not say the first generic caused the fall, and it does not say this product's price will follow the median. See it with other drugs.
How many companies make Entecavir?
The FDA Orange Book lists 8 generic makers as marketed in its largest dosage form for Entecavir, and the first generic approval is dated 26 August 2014. The acquisition costs above are what pharmacies pay across the NDCs priced; the Orange Book count is a separate record and this page does not say that more makers lowered a price. See each maker and the patents still listed on OmniRx.